Since the spread of COVID-19, dedicated researchers from all over the world worked round the clock to unveil the identity of the new virus and find ways to bring the deadly pandemic to an end. Basic science virologists revealed facts about the viral life cycle, cell entry, replication, and emerging variants. Epidemiologists carefully tracked the disease's transmission dynamics. Immunologists studied detailed immune response to infection. Pharmacologists performed drug design and drug repurposing studies. Biotechnologists designed and developed vaccines and efficient diagnostic techniques. Physicians and pathologists investigated symptoms and pathogenesis of infection and developed therapeutic management strategies to help rescue critical cases. In addition, many case reports and clinical trials have been performed, and many other social and economic aspects of the pandemic have been studied.The flood of research articles related to COVID-19 has been very difficult to track with thousands of articles being published at an accelerated rate in a short time. By December 20, 2021, in terms of basic science and medical research, searching "COVID-19" at PubMed returns 211 708 publications, while "SARS CoV-2" returns 133 073 results [1].This breathtaking speed of the medical research response to the pandemic has come with mixed consequences. On the positive side, there has been a greater provision of open access to COVID-19 studies, increased institutional collaboration, expedited ethical approvals of new studies, and prompter use of preprints. On the negative side, time pressure, along with inadequate infrastructure, amplified the problems of research waste due to poor questions, design and performance, lack of or poor reporting of results, and other redundancies [2].